{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:59:40Z","timestamp":1786996780645,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.semnephrol.2018.05.002","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T15:45:55Z","timestamp":1533311155000},"page":"317-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genetics, Genomics, and Precision Medicine in End-Stage Kidney Disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Jeffrey B.","family":"Kopp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2018.05.002_bib0001","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.semnephrol.2016.12.002","article-title":"Evolution of cardiovascular disease during the transition to end-stage renal disease","volume":"37","author":"Bansal","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5414\/CNP86S114","article-title":"Chronic kidney disease and end-stage renal disease in disadvantaged communities of North America: an investigational challenge to limit disease progression and cardiovascular risk","volume":"86","author":"Regunathan-Shenk","year":"2016","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0003","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/heartjnl-2016-310794","article-title":"Heart failure in patients with kidney disease","volume":"103","author":"Tuegel","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0004","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/heartasia-2016-010809","article-title":"Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup","volume":"8","author":"Subbiah","year":"2016","journal-title":"Heart Asia"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0005","doi-asserted-by":"crossref","first-page":"F938","DOI":"10.1152\/ajprenal.00256.2017","article-title":"Inflammation and premature aging in advanced chronic kidney disease","volume":"313","author":"Kooman","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0006","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11892-017-0906-z","article-title":"Progress in defining the genetic basis of diabetic complications","volume":"17","author":"Dahlstrom","year":"2017","journal-title":"Curr Diab Rep"},{"issue":"32 Suppl 2","key":"10.1016\/j.semnephrol.2018.05.002_bib0007","article-title":"Genetic epidemiology in kidney disease","author":"Ainsworth","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0008","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000481886","article-title":"Genome-wide analysis studies and chronic kidney disease","volume":"3","author":"Piras","year":"2017","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000484327","article-title":"Heritability of end-stage renal disease: a Swedish adoption study","volume":"138","author":"Akrawi","year":"2018","journal-title":"Nephron"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jdi.12391","article-title":"Genetics of cardiovascular and renal complications in diabetes","volume":"7","author":"Ma","year":"2016","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0011","doi-asserted-by":"crossref","first-page":"e88273","DOI":"10.1371\/journal.pone.0088273","article-title":"Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease","volume":"9","author":"Palmer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0012","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1681\/ASN.2016020231","article-title":"The genetic landscape of renal complications in type 1 diabetes","volume":"28","author":"Sandholm","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0013","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0014","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.232","article-title":"MYH9 is associated with nondiabetic end-stage renal disease in African Americans","volume":"40","author":"Kao","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0015","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrneph.2017.129","article-title":"Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases","volume":"13","author":"Cybulsky","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0016","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000441199","article-title":"Association analysis of the reticulon 1 gene in end-stage kidney disease","volume":"42","author":"Bonomo","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0017","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.ajkd.2011.09.020","article-title":"Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy","volume":"59","author":"Bostrom","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0018","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2014.255","article-title":"APOL1 associations with nephropathy, athersclerosis, and all-cause mortality in African Americans with type 2 diabetes","volume":"87","author":"Freedman","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0019","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1093\/hmg\/ddu362","article-title":"The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease","volume":"23","author":"Bonomo","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0020","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1681\/ASN.2017030228","article-title":"The loss of GSTM1 associates with kidney failure and heart failure","volume":"28","author":"Tin","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0021","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1681\/ASN.2013111205","article-title":"Length polymorphism in heme oxygenase-1 and risk of CKD among patients with coronary artery disease","volume":"25","author":"Chen","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0022","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2016101086","article-title":"Sickle cell trait and the risk of ESRD in blacks","volume":"28","author":"Naik","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0023","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1681\/ASN.2011101019","article-title":"Vasculature and kidney complications in sickle cell disease","volume":"23","author":"Nath","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0024","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ckj\/sfx039","article-title":"A clinical-genetic approach to assessing cardiovascular risk in patients with CKD","volume":"10","author":"Rodrigo","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0025","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.ajkd.2008.12.025","article-title":"Association of single-nucleotide polymorphisms in JAK3, STAT4, and STAT6 with new cardiovascular events in incident dialysis patients","volume":"53","author":"Sperati","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0026","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/157016112803520756","article-title":"SIRT1 - an anti-inflammatory pathway at the crossroads between metabolic disease and atherosclerosis","volume":"10","author":"Winnik","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0027","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.jrn.2011.10.025","article-title":"SIRTUIN 1 gene polymorphisms are associated with cholesterol metabolism and coronary artery calcification in Japanese hemodialysis patients","volume":"22","author":"Shimoyama","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0028","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/ATVBAHA.117.309566","article-title":"Circulating mcroRNA-125b predicts the presence and progression of uremic vascular calcification","volume":"37","author":"Chao","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0029","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0031","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0032","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2011040434","article-title":"APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy","volume":"22","author":"Papeta","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0033","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1681\/ASN.2011060562","article-title":"APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease","volume":"23","author":"Fine","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0034","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ki.2012.263","article-title":"Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans","volume":"83","author":"Lipkowitz","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0036","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2012121180","article-title":"Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy","volume":"24","author":"Larsen","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0037","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0038","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.38220","article-title":"End-stage renal disease in African Americans with lupus nephritis is associated with APOL1","volume":"66","author":"Freedman","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0039","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1681\/ASN.2015070763","article-title":"Race, APOL1 risk, and eGFR decline in the general population","volume":"27","author":"Grams","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0040","doi-asserted-by":"crossref","unstructured":"Foster MC, Coresh J, Fornage M, et al. APOL1 variants associated with increased risk of CKD among African Americans. 2013;24:1484-91.","DOI":"10.1681\/ASN.2013010113"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0041","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1681\/ASN.2014050474","article-title":"Effect of genetic African ancestry on eGFR and kidney disease","volume":"26","author":"Udler","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0042","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12882-015-0008-6","article-title":"Apoliopoprotein L1, income and early kidney disease","volume":"16","author":"Tamrat","year":"2015","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0043","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00439-016-1714-2","article-title":"Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans","volume":"135","author":"Guan","year":"2016","journal-title":"Hum Genet"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0044","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2010121234","article-title":"Genetic variation in APOL1 associates with younger age at hemodialysis initiation","volume":"22","author":"Kanji","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0045","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/ndt\/gfr796","article-title":"APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease","volume":"27","author":"Tzur","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0046","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.kint.2016.02.032","article-title":"APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease","volume":"90","author":"Ma","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0047","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2215\/CJN.08340814","article-title":"Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study","volume":"10","author":"Tin","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0048","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.semnephrol.2017.07.005","article-title":"The expanding role of APOL1 risk in chronic kidney disease and cardiovascular disease","volume":"37","author":"Estrella","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0049","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fped.2016.00122","article-title":"Renal and cardiovascular morbidities associated with APOL1 status among African-American and non-African-American children with focal segmental glomerulosclerosis","volume":"4","author":"Woroniecki","year":"2016","journal-title":"Front Pediatr"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0050","unstructured":"National Institutes of Health. The Future of Health Begins with you. Available at: https:\/\/allofus.nih.gov\/."},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0051","series-title":"USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health","year":"2017"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0052","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.semnephrol.2017.07.005","article-title":"The expanding role of APOL1 risk in chronic kidney disease and cardiovascular disease","volume":"37","author":"Estrella","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0053","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fped.2016.00122","article-title":"Renal and cardiovascular morbidities associated with APOL1 status among African-American and non-Africian-American children with focal segmental glomerulosclerosis","volume":"4","author":"Woroniecki","year":"2016","journal-title":"Front Pediatr"},{"key":"10.1016\/j.semnephrol.2018.05.002_bib0054","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/ATVBAHA.115.305970","article-title":"APOL1 genotype, kidney and cardiovascular disease, and death in older adults","volume":"36","author":"Mukamal","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929518300536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929518300536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T16:42:15Z","timestamp":1571676135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929518300536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0270929518300536"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.002","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics, Genomics, and Precision Medicine in End-Stage Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}